These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 30204156)

  • 1. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.
    Wang M; Beckmann ND; Roussos P; Wang E; Zhou X; Wang Q; Ming C; Neff R; Ma W; Fullard JF; Hauberg ME; Bendl J; Peters MA; Logsdon B; Wang P; Mahajan M; Mangravite LM; Dammer EB; Duong DM; Lah JJ; Seyfried NT; Levey AI; Buxbaum JD; Ehrlich M; Gandy S; Katsel P; Haroutunian V; Schadt E; Zhang B
    Sci Data; 2018 Sep; 5():180185. PubMed ID: 30204156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease.
    Galea E; Weinstock LD; Larramona-Arcas R; Pybus AF; Giménez-Llort L; Escartin C; Wood LB
    Neurobiol Dis; 2022 May; 166():105655. PubMed ID: 35143967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer's disease.
    Lin CX; Li HD; Deng C; Liu W; Erhardt S; Wu FX; Zhao XM; Guan Y; Wang J; Wang D; Hu B; Wang J
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34953465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal transcriptome-wide association study and neurobiological pathway analysis for Alzheimer's disease.
    Liu N; Xu J; Liu H; Zhang S; Li M; Zhou Y; Qin W; Li MJ; Yu C;
    PLoS Genet; 2021 Feb; 17(2):e1009363. PubMed ID: 33630843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.
    Saykin AJ; Shen L; Yao X; Kim S; Nho K; Risacher SL; Ramanan VK; Foroud TM; Faber KM; Sarwar N; Munsie LM; Hu X; Soares HD; Potkin SG; Thompson PM; Kauwe JS; Kaddurah-Daouk R; Green RC; Toga AW; Weiner MW;
    Alzheimers Dement; 2015 Jul; 11(7):792-814. PubMed ID: 26194313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy.
    Ferrari R; Ferrara M; Alinani A; Sutton RB; Famà F; Picco A; Rodriguez G; Nobili F; Momeni P
    Curr Alzheimer Res; 2015; 12(8):802-12. PubMed ID: 26159191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for integrative multi-omic approaches to explore Alzheimer's disease mechanisms.
    Ma Y; Klein HU; De Jager PL
    Brain Pathol; 2020 Sep; 30(5):984-991. PubMed ID: 32654306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
    Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of genetic difference between mild cognitive impairment and Alzheimer's disease through genome-wide association study].
    Bai Z; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):342-346. PubMed ID: 29896728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease.
    Xie L; He B; Varathan P; Nho K; Risacher SL; Saykin AJ; Salama P; Yan J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33971669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic variants, genes, and pathways of Alzheimer's disease: An overview.
    Naj AC; Schellenberg GD;
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):5-26. PubMed ID: 27943641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment.
    Li L; Yang Y; Zhang Q; Wang J; Jiang J; Neuroimaging Initiative AD
    Behav Neurol; 2021; 2021():3359103. PubMed ID: 34336000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
    Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
    Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.
    Karch CM; Ezerskiy LA; Bertelsen S; ; Goate AM
    PLoS One; 2016; 11(2):e0148717. PubMed ID: 26919393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample.
    Guffanti G; Torri F; Rasmussen J; Clark AP; Lakatos A; Turner JA; Fallon JH; Saykin AJ; Weiner M; ; Vawter MP; Knowles JA; Potkin SG; Macciardi F
    Genomics; 2013 Aug; 102(2):112-22. PubMed ID: 23583670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains.
    Varathan P; Gorijala P; Jacobson T; Chasioti D; Nho K; Risacher SL; Saykin AJ; Yan J
    BMC Med Genomics; 2022 Apr; 15(Suppl 2):93. PubMed ID: 35461270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology.
    Ray NR; Ayodele T; Jean-Francois M; Baez P; Fernandez V; Bradley J; Crane PK; Dalgard CL; Kuzma A; Nicaretta H; Sims R; Williams J; Cuccaro ML; Pericak-Vance MA; Mayeux R; Wang LS; Schellenberg GD; Cruchaga C; Beecham GW; Reitz C
    Alzheimers Dement; 2023 Sep; 19(9):4187-4195. PubMed ID: 37390458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study identifies two loci influencing plasma neurofilament light levels.
    Li JQ; Yuan XZ; Li HY; Cao XP; Yu JT; Tan L; Chen WA;
    BMC Med Genomics; 2018 May; 11(1):47. PubMed ID: 29747637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.